Identification, characterization and mechanisms of action of new tumor-associated lymphangiogenesis inhibitors

Project Information

TUMORLYMPHAINHIBIT

Grant agreement ID: 625862

Project closed

Start date 1 April 2014

End date 31 March 2016

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 169 800,00

EU contribution € 169 800,00

Coordinated by

UNIVERSITE DE LIEGE
Belgium